Clinical Trials Directory

Trials / Unknown

UnknownNCT03238014

Efficacy of High-intensity NPPV and Low-intensity NPPV in Patients With Chronic Hypercapnic COPD

Efficacy of High-intensity Noninvasive Positive Pressure Ventilation and Low-intensity Noninvasive Positive Pressure Ventilation in Patients With Chronic Hypercapnic Chronic Obstructive Pulmonary Disease

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
14 (estimated)
Sponsor
The First Affiliated Hospital of Guangzhou Medical University · Academic / Other
Sex
All
Age
40 Years – 80 Years
Healthy volunteers
Not accepted

Summary

High-intensity noninvasive positive pressure ventilation (NPPV), which can well improve the gas exchange and reduce the work of breathing of patients, is a new strategy targeted at maximally reducing arterial carbon dioxide. However, no definitive conclusions have been drawn to decide whether high-intensity NPPV is the best setting for treating patients with chronic hypercapnic COPD. For now, no unified method for setting up high-pressure NPPV has been established. Most of the trials utilized gradually increased inspiratory positive airway pressure depending on the patient's tolerance. However, from a respiratory physiology point of view, excessive inspiratory positive airway pressure may lead to lung hyperinflation, increased intrinsic positive end expiratory pressures, increased oxygen consumption, and ineffective work of breathing.Therefore, seeking a method to establish individualized high-intensity NPPV is of vital importance.

Conditions

Interventions

TypeNameDescription
DEVICENoninvasive positive pressure ventilationNoninvasive positive pressure ventilation used assist/control mode treat severe stable chronic obstructive pulmonary disease.

Timeline

Start date
2017-08-01
Primary completion
2020-05-01
Completion
2020-05-01
First posted
2017-08-03
Last updated
2020-02-05

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03238014. Inclusion in this directory is not an endorsement.